TH

Tasuku Honjo

OC Ono Pharmaceutical Co.: 29 patents #7 of 559Top 2%
UN Unknown: 18 patents #256 of 83,584Top 1%
TH Tasuku Honjo: 5 patents #1 of 13Top 8%
KU Kyoto University: 3 patents #177 of 1,688Top 15%
SL Suntory Holdings Limited: 2 patents #246 of 846Top 30%
JT Japan Tobacco: 2 patents #330 of 1,187Top 30%
TI Takeda Chemical Industries: 1 patents #745 of 1,420Top 55%
JT Japan Science And Technology: 1 patents #225 of 836Top 30%
Overall (All Time): #79,115 of 4,157,543Top 2%
40
Patents All Time

Issued Patents All Time

Showing 1–25 of 40 patents

Patent #TitleCo-InventorsDate
11662339 Efficacy determination markers in disease treatment by PD-1 signal inhibitor Kenji CHAMOTO, Fumihiko Matsuda, Yasushi Okuno, Sidonia Fagarasan 2023-05-30
9783609 Substance specific to human PD-1 Shiro Shibayama, Kazuhiko Takeda, Masayoshi Matsuo, Takao Yoshida, Masakazu Miyamoto 2017-10-10
9439962 Immunopotentiative composition Nagahiro Minato, Yoshiko Iwai, Shiro Shibayama 2016-09-13
9402899 Immunopotentiative composition Nagahiro Minato, Yoshiko Iwai, Shiro Shibayama 2016-08-02
9393301 Immunopotentiative composition Nagahiro Minato, Yoshiko Iwai, Shiro Shibayama 2016-07-19
9073994 Immunopotentiative composition Nagahiro Minato, Yoshiko Iwai, Shiro Shibayama 2015-07-07
9067999 Immunopotentiative composition Nagahiro Minato, Yoshiko Iwai, Shiro Shibayama 2015-06-30
8951518 Substance specific to human PD-1 Shiro Shibayama, Kazuhiko Takeda, Masayoshi Matsuo, Takao Yoshida, Masakazu Miyamoto 2015-02-10
8728474 Immunopotentiative composition Nagahiro Minato, Yoshiko Iwai, Shiro Shibayama 2014-05-20
8246955 Substance specific to human PD-1 Shiro Shibayama, Kazuhiko Takeda, Masayoshi Matsuo, Takao Yoshida, Masakazu Miyamoto 2012-08-21
8168179 Treatment method using anti-PD-L1 antibody Nagahiro Minato, Yoshiko Iwai, Shiro Shibayama 2012-05-01
7998479 Substance specific to human PD-1 Shiro Shibayama, Kazuhiko Takeda, Masayoshi Matsuo, Takao Yoshida, Masakazu Miyamoto 2011-08-16
7998491 Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide Kei Tashiro, Kazuhiro Kobuke 2011-08-16
7858746 Substance that specifically recognizes PD-1 Shiro Shibayama, Masayoshi Matsuo, Takao Yoshida 2010-12-28
7794975 Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide Kei Tashiro, Kazuhiro Kobuke 2010-09-14
7749758 Human and mammalian stem cell-derived neuron survival factors Kei Tashiro, Jun Takahashi, Hiroki Toda 2010-07-06
7662620 Human and mammalian stem cell-derived neuron survival factors Kei Tashiro, Jun Takahashi, Hiroki Toda 2010-02-16
7595048 Method for treatment of cancer by inhibiting the immunosuppressive signal induced by PD-1 Nagahiro Minato, Yoshiko Iwai, Shiro Shibayama 2009-09-29
7563869 Substance specific to human PD-1 Shiro Shibayama, Kazuhiko Takeda, Masayoshi Matsuo, Takao Yoshida, Masakazu Miyamoto 2009-07-21
7414171 PD-1-lacking mouse and use thereof Hiroyuki Nishimura 2008-08-19
7407767 Method of screening remedy for heart disease and medicinal composition for treating heart disease Taku Okazaki 2008-08-05
7314621 Cytidine deaminase Masamichi Muramatsu 2008-01-01
7273725 Human and mammalian stem cell-derived neuron survival factors Kei Tashiro, Jun Takahashi, Hiroki Toda 2007-09-25
7255998 High sensitivity immunoassay method Kei Tashiro, Masaya Ikegawa, Kazuko Matsumoto 2007-08-14
7217786 Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide Kei Tashiro, Kazuhiro Kobuke 2007-05-15